Related references
Note: Only part of the references are listed.Functional Characteristics of Two Human MATE Transporters: Kinetics of Cimetidine Transport and Profiles of Iinhibition by Various Compounds
Kin-ya Ohta et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2016)
Organic cation transporter OCT/SLC22A and H+/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents
Atsushi Yonezawa et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations
J. Koenig et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
OCT2 and MATE1 Provide Bidirectional Agmatine Transport
Tate N. Winter et al.
MOLECULAR PHARMACEUTICS (2011)
Effects of Metabolic Acidosis on Expression Levels of Renal Drug Transporters
Arong Gaowa et al.
PHARMACEUTICAL RESEARCH (2011)
Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
Giuliano Ciarimboli et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
mTOR inhibitor everolimus ameliorates progressive tubular dysfunction in chronic renal failure rats
Shunsaku Nakagawa et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity
Takanori Nakamura et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Pharmacokinetic Interaction between JBP485 and Cephalexin in Rats
Jian Zhang et al.
DRUG METABOLISM AND DISPOSITION (2010)
Evaluation of 4 ',6-Diamidino-2-phenylindole as a Fluorescent Probe Substrate for Rapid Assays of the Functionality of Human Multidrug and Toxin Extrusion Proteins
Tomoya Yasujima et al.
DRUG METABOLISM AND DISPOSITION (2010)
Potent and Specific Inhibition of mMate1-Mediated Efflux of Type I Organic Cations in the Liver and Kidney by Pyrimethamine
Sumito Ito et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Reduced Renal Clearance of a Zwitterionic Substrate Cephalexin in Mate1-Deficient Mice
Shingo Watanabe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Preclinical and Clinical Evidence for the Collaborative Transport and Renal Secretion of an Oxazolidinone Antibiotic by Organic Anion Transporter 3 (OAT3/SLC22A8) and Multidrug and Toxin Extrusion Protein 1 (MATE1/SLC47A1)
Yurong Lai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Structure and Basal Transcription Complex of RNA Polymerase II Core Promoters in the Mammalian Genome: An Overview
Martina Baumann et al.
MOLECULAR BIOTECHNOLOGY (2010)
Structure of a cation-bound multidrug and toxic compound extrusion transporter
Xiao He et al.
NATURE (2010)
Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
Matthijs L. Becker et al.
PHARMACOGENETICS AND GENOMICS (2010)
Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients
Kana Toyama et al.
PHARMACOGENETICS AND GENOMICS (2010)
Alterations in Hepatic mRNA Expression of Phase II Enzymes and Xenobiotic Transporters after Targeted Disruption of Hepatocyte Nuclear Factor 4 Alpha
Hong Lu et al.
TOXICOLOGICAL SCIENCES (2010)
Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms
Henriette E. Meyer Zu Schwabedissen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
K. K. Filipski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
Matth S. L. Becker et al.
DIABETES (2009)
The Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by Cimetidine
Soichiro Matsushima et al.
DRUG METABOLISM AND DISPOSITION (2009)
Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity
Moto Kajiwara et al.
JOURNAL OF HUMAN GENETICS (2009)
Functional Characterization of Multidrug and Toxin Extrusion Protein 1 as a Facilitative Transporter for Fluoroquinolones
Kin-ya Ohta et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Involvement of Human Multidrug and Toxin Extrusion 1 in the Drug Interaction between Cimetidine and Metformin in Renal Epithelial Cells
Masahiro Tsuda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Targeted Disruption of the Multidrug and Toxin Extrusion 1 (Mate1) Gene in Mice Reduces Renal Secretion of Metformin
Masahiro Tsuda et al.
MOLECULAR PHARMACOLOGY (2009)
Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1
Ji Ha Choi et al.
PHARMACOGENETICS AND GENOMICS (2009)
Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function
Ying Chen et al.
PHARMACOGENOMICS JOURNAL (2009)
MATE1 has an external COOH terminus, consistent with a 13-helix topology
Xiaohong Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Role of glutamate residues in substrate recognition by human MATE1 polyspecific H+/organic cation exporter
Takuya Matsumoto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A)
Tomohiro Terada et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1
Tomoko Sato et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice
Andrew J. Lickteig et al.
LIFE SCIENCES (2008)
Regulation of renal organic ion transporters in cisplatin-induced acute kidney injury and uremia in rats
Takafumi Morisaki et al.
PHARMACEUTICAL RESEARCH (2008)
Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation:: An in vitro-in vivo study
B. Feng et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury
Takanobu Matsuzaki et al.
DRUG METABOLISM AND DISPOSITION (2008)
Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1
Moto Kajiwara et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Functional characterization of testis-specific rodent multidrug and toxic compound extrusion 2, a class III MATE-type polyspecific H+/organic cation exporter
Miki Hiasa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity
Sachiko Yokoo et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family
Ying Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H+-organic cation antiporters
Yuko Tanihara et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Molecular identification and functional characterization of rabbit MATE1 and MATE2-K
Xiaohong Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications
Hermann Koepsell et al.
PHARMACEUTICAL RESEARCH (2007)
Identification of essential histidine and cysteine residues of the H+/organic cation antiporter multidrug and toxin extrusion (MATE)
Jun-ichi Asaka et al.
MOLECULAR PHARMACOLOGY (2007)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Pharmacokinetic significance of luminal multidrug and toxin extrusion 1 in chronic renal failure rats
Kumiko Nishihara et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1
Masahiro Tsuda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)
Atsushi Yonezawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Molecular identification and functional characterization of rat multidrug and toxin extrusion type transporter 1 as an organic cation/H+ antiporter in the kidney
Kin-ya Ohta et al.
DRUG METABOLISM AND DISPOSITION (2006)
The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations
Hiroshi Omote et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1
Tomohiro Terada et al.
PHARMACEUTICAL RESEARCH (2006)
Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2
Satohiro Masuda et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
A human transporter protein that mediates the final excretion step for toxic organic cations
M Otsuka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations
JW Jonker et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Effect of cimetidine and probenecid on pilsicainide renal clearance in humans
T Shiga et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Share Paper
